425 related articles for article (PubMed ID: 26621819)
21. Effects of single-dose intravenous omeprazole and ranitidine on gastric pH during general anesthesia.
Atanassoff PG; Alon E; Pasch T
Anesth Analg; 1992 Jul; 75(1):95-8. PubMed ID: 1616168
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of the therapeutic use of proton pump inhibitor (PPI) by measurement of 24 hour the intra-gastric pH].
Yamagata S
Nihon Rinsho; 1992 Jan; 50(1):160-6. PubMed ID: 1347328
[TBL] [Abstract][Full Text] [Related]
23. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
24. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
25. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
26. Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.
Houben GM; Hooi J; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 1995 Dec; 9(6):649-54. PubMed ID: 8824652
[TBL] [Abstract][Full Text] [Related]
27. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
28. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Habu Y; Oyasu K; Wakamatsu T; Sumitomo Y; Kiyota K; Inokuchi H; Kawai K
Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
[TBL] [Abstract][Full Text] [Related]
30. Effect of gastric acid suppressants on human gastric motility.
Parkman HP; Urbain JL; Knight LC; Brown KL; Trate DM; Miller MA; Maurer AH; Fisher RS
Gut; 1998 Feb; 42(2):243-50. PubMed ID: 9536950
[TBL] [Abstract][Full Text] [Related]
31. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
Orr WC; Mellow MH; Grossman MR
Aliment Pharmacol Ther; 1995 Oct; 9(5):571-4. PubMed ID: 8580280
[TBL] [Abstract][Full Text] [Related]
32. The time course of gastric pH changes induced by omeprazole and ranitidine: a 24-hour dose-response study.
Atanassoff PG; Brull SJ; Weiss BM; Landefeld K; Alon E; Rohling R
Anesth Analg; 1995 May; 80(5):975-9. PubMed ID: 7726442
[TBL] [Abstract][Full Text] [Related]
33. [Utility of premedication with different regimens of omeprazole and ranitidine in the prevention of acid broncho-aspiration syndrome].
Navas E; Luis-Navarro JC
Rev Esp Anestesiol Reanim; 1992; 39(6):337-40. PubMed ID: 1293650
[TBL] [Abstract][Full Text] [Related]
34. Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
Peddicord TE; Olsen KM; Collier DS
Crit Care Med; 1999 Jan; 27(1):90-4. PubMed ID: 9934899
[TBL] [Abstract][Full Text] [Related]
35. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Collen MJ; Strong RM
Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
[TBL] [Abstract][Full Text] [Related]
36. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
Peghini PL; Katz PO; Castell DO
Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of extended-interval dosing of omeprazole in keeping gastroesophageal reflux disease patients symptom free.
Bieszk N; Kale-Pradhan PB
Ann Pharmacother; 1999 May; 33(5):638-41. PubMed ID: 10369630
[TBL] [Abstract][Full Text] [Related]
38. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
Kiilerich S; Rannem T; Elsborg L
Digestion; 1995; 56(1):25-30. PubMed ID: 7895928
[TBL] [Abstract][Full Text] [Related]
39. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
[TBL] [Abstract][Full Text] [Related]
40. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.
Jeppesen PB; Staun M; Tjellesen L; Mortensen PB
Gut; 1998 Dec; 43(6):763-9. PubMed ID: 9824602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
